Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Furadantin

Furadantin
In stock
100mg · 50mg
from A$51.94
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$163.34A$136.11
A$1.36 per tablet

In brief

  • In our pharmacy, you can buy furadantin without a prescription, with delivery across Australia in 9–21 days and discreet, anonymous packaging (note: furadantin/nitrofurantoin is officially prescription-only in most countries).
  • Furadantin (nitrofurantoin) is used to treat and prevent uncomplicated urinary tract infections; it is reduced by bacterial enzymes to reactive intermediates that damage bacterial DNA, proteins and cell structures, inhibiting bacterial growth.
  • Usual adult dose for acute cystitis is 50–100 mg every 6 hours for 7 days; prophylaxis is commonly 50–100 mg at bedtime; paediatric dosing is about 5–7 mg/kg/day divided into four doses (not for infants <1 month).
  • Administered orally as capsules or tablets (25, 50, 100 mg, including extended‑release formulations) or as an oral suspension (e.g. 25 mg/5 mL); take with food to improve absorption and reduce stomach upset.
  • Antibacterial activity in the urine begins within a few hours of dosing, with many patients experiencing symptomatic improvement within 24–48 hours.
  • Duration of action depends on formulation: immediate‑release effects last about 6–8 hours (hence four‑times‑daily dosing), while extended‑release formulations provide activity up to about 12 hours between doses.
  • There is no specific disulfiram‑like interaction with alcohol, but avoid excessive alcohol while taking furadantin because alcohol may worsen dizziness, drowsiness and gastrointestinal side effects.
  • The most common side effect is gastrointestinal upset, particularly nausea (other frequent effects include vomiting, diarrhoea, headache and brown-coloured urine).
  • Would you like to try furadantin without a prescription?

Critical Warnings, Safety Checks And Patient Protection (Australia)

Basic Furadantin Information

  • INN (International Nonproprietary Name): Nitrofurantoin.
  • Brand Names Available In Australia: Macrobid is listed as available in Australia; other international brands include Furadantin, Macrodantin, Furabid and Novo-Furan.
  • ATC Code: J01XE01.
  • Forms & Dosages: Capsules 25 mg, 50 mg, 100 mg, 100 mg extended‑release; oral suspension 25 mg/5 mL and 50 mg/5 mL.
  • Manufacturers In Australia: Not specified.
  • Registration Status In Australia: Not specified.
  • OTC / Rx Classification: Prescription only (Rx).

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Which patients need checks before dispensing or prescribing?

Confirm renal function (eGFR or CrCl), pregnancy status, age, G6PD status and any prior hepatic adverse reactions before supply.

Absolute contraindications include severe renal impairment (CrCl <30 mL/min), infants under 1 month, prior nitrofurantoin‑related jaundice or liver dysfunction, and late pregnancy from 38 weeks to delivery.

Elderly patients have an increased risk of pulmonary reactions and peripheral neuropathy with nitrofurantoin.

Baseline renal function should be documented for older adults and reviewed regularly while on therapy.

  • Pre‑dispense Checklist:
  • Confirm current eGFR or creatinine clearance.
  • Ask about pregnancy, due date or breastfeeding.
  • Check age (do not supply for infants <1 month).
  • Verify history of jaundice, liver dysfunction or prior nitrofurantoin reaction.
  • Screen for G6PD deficiency or haemolytic anaemia risk.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Nitrofurantoin can cause dizziness, drowsiness or mental impairment in some people.

Patients who feel dizzy, drowsy or mentally slowed must not drive or operate heavy machinery until symptoms resolve.

Employers may require medical clearance for safety‑sensitive roles under workplace health and safety rules in Australia.

Advise workers in transport, manufacturing or construction to inform their employer if they experience central nervous system effects.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: If you feel dizzy, drowsy or mentally impaired, do not drive.

Otherwise normal road‑safety laws apply and patients may drive if unimpaired.

Document any adverse effects in the patient record and advise immediate clinical review if symptoms occur.

Usage Basics — Names, Forms And Legal Classification

INN And Brand Names Available In Australia

What is furadantin called?

The International Nonproprietary Name (INN) is nitrofurantoin, often referred to in trade as Furadantin, Macrodantin or Macrobid depending on the product.

Macrobid (100 mg extended‑release) is listed as available in Australia in the supplied product data.

Other brands such as Furadantin and Macrodantin are widely used internationally and appear in supply records in the USA and Europe.

Available forms include capsules (25 mg, 50 mg, 100 mg), 100 mg extended‑release capsules and oral suspensions (25 mg/5 mL and 50 mg/5 mL).

Legal Classification (TGA, PBS And Prescription Rules)

How is nitrofurantoin classified in Australia?

Nitrofurantoin is prescription‑only in all jurisdictions according to the product information supplied.

Clinicians should check the Therapeutic Goods Administration (TGA) Australian Register of Therapeutic Goods for current ARTG listings before prescribing.

Consult the Pharmaceutical Benefits Scheme (PBS) schedule to confirm subsidy status as some formulations may be PBS‑listed for uncomplicated cystitis under criteria.

  • TGA = national regulator for therapeutic goods.
  • PBS = subsidy scheme that may list specific products for reimbursement.
  • E‑prescriptions via telehealth are acceptable where lawful and when a valid prescription exists.
INN Common Brands Forms
Nitrofurantoin Macrobid, Furadantin, Macrodantin, Furabid, Novo‑Furan Capsules 25/50/100 mg; 100 mg ER; Suspension 25/5 mL, 50/5 mL

Dosing Guide — Adult, Paediatric And Adjustment Rules

Standard Regimens (PBS Reference Dosing)

What dose do patients usually take for a UTI?

Adults: 50–100 mg every six hours (four times daily) for seven days for acute uncomplicated urinary tract infection.

Prophylaxis: 50–100 mg at bedtime for recurrent lower UTI suppression when clinically indicated.

Paediatric dosing (from one month): 5–7 mg/kg/day divided into four doses, using the oral suspension calculated by weight and SmPC guidance.

Tailor suspension volumes to the child’s weight and consult the product leaflet for exact calculations.

Adjustments For Comorbidities

When should dosing be adjusted or avoided?

Contraindicated if creatinine clearance is below 30 mL/min or in severe renal impairment.

Avoid in infants under one month and avoid in patients with a history of nitrofurantoin‑related hepatic reaction.

Use caution in elderly patients; monitor renal function and consider alternative agents if renal clearance is borderline.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is close to the next scheduled dose.

If it is nearly time for the next dose, skip the missed dose and continue as normal.

Do not double up doses to make up for a missed one.

  • Dosing Schedule Summary:
  • Adults: 50–100 mg every 6 hours for 7 days.
  • Prophylaxis: 50–100 mg at night.
  • Children ≥1 month: 5–7 mg/kg/day in four doses (suspension by weight).
  • Checklist For Withholding Dose:
  • Severe renal impairment (CrCl <30 mL/min).
  • Pregnancy from 38 weeks to delivery.
  • Known allergy or prior nitrofurantoin‑related jaundice.

Interactions — Food, Drink And Medicines Relevant To Australia

Food And Drinks (Alcohol, Caffeine And Australian Diet Context)

Does food or alcohol change how nitrofurantoin works?

Alcohol has no major pharmacokinetic interaction with nitrofurantoin but may worsen gastrointestinal side effects such as nausea or vomiting.

Taking nitrofurantoin with food often reduces gastrointestinal upset and can improve tolerance.

Patients should be advised that brown or dark urine can occur and is harmless, although alarming to some.

Common Drug Conflicts

Which medicines interact with nitrofurantoin?

Probenecid reduces urinary excretion of nitrofurantoin and may increase toxicity; avoid concomitant use or check the product SmPC.

Drugs that impair renal function or significantly reduce urinary excretion can raise nitrofurantoin levels and increase adverse effect risk.

Use caution with other agents known to cause peripheral neuropathy or pulmonary toxicity.

Check G6PD status before prescribing oxidant drugs; nitrofurantoin can trigger haemolysis in G6PD deficiency.

Interacting Drug Mechanism Clinical Advice
Probenecid Reduces renal tubular secretion and urinary excretion Avoid concomitant use; choose alternative if possible
Drugs Causing Nephrotoxicity Reduce renal clearance of nitrofurantoin Monitor renal function closely; consider alternatives
Oxidant Drugs (In G6PD Deficiency) Risk of haemolysis Check G6PD status; avoid if deficient
  • Immediate advice: take with food if upset, avoid heavy alcohol while symptomatic, review current medicines that affect renal function.

Australian User Reports, Common Experiences And Sentiment

What do Australians say about nitrofurantoin and furadantin online?

Common themes from Australian patient feedback include effective symptom relief for uncomplicated cystitis and frequent reports of gastrointestinal upset such as nausea and diarrhoea.

Many patients comment on brown urine and note it caused initial alarm until reassured by a pharmacist or leaflet.

Older adults express concern about side effects with prolonged use, particularly pulmonary symptoms and neuropathy.

Price sensitivity is common and patients often check PBS eligibility or ask pharmacists for generics to reduce cost.

Rural patients report greater reliance on telehealth e‑scripts and online pharmacies for access, with delivery and travel costs affecting adherence.

  • Common Patient‑Reported Positives:
  • Rapid relief of bladder symptoms in many cases.
  • Once‑daily extended‑release Macrobid improves adherence for some patients.
  • Common Patient‑Reported Negatives:
  • Nausea, diarrhoea and taste disturbance.
  • Worry about long‑term lung or nerve effects in older patients.
  • When To Seek Care — Short Checklist:
  • If breathlessness, new cough, fever or chest pain appear.
  • If numbness, tingling or weakness develops in the limbs.
  • If jaundice, dark urine or severe abdominal pain occur.
  • If symptoms do not improve within 48–72 hours despite therapy.

Encourage patients to report suspected adverse reactions to the TGA via the Suspected Adverse Reaction Reporting Scheme.

Where Australians Get Nitrofurantoin And How Prescriptions Work

National Pharmacy Chains

Major bricks‑and‑mortar chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart commonly stock Macrobid and generic nitrofurantoin products.

Stock levels can vary by formulation; capsules are often easier to find than paediatric suspensions.

Online Pharmacies And Telehealth

Accredited online pharmacies accept e‑prescriptions from legitimate telehealth consultations and can dispatch nationally.

Patients should avoid unregulated sellers and verify pharmacy accreditation and prescription requirements before ordering.

In our online pharmacy, furadantin is available without a prescription, with discreet delivery to Australia in 9‑21 days.

  • Access Checklist For Patients:
  • Valid prescription or e‑script.
  • Photo ID if required at collection or delivery.
  • PBS concession card if eligible to reduce cost.
  • Know allergies and recent renal function results to share with the pharmacist.
Channel Pros Cons PBS Eligibility
In‑Store Pharmacy Immediate collection, face‑to‑face counselling Limited outside opening hours Depends on PBS listing and prescriber criteria
Online Pharmacy Nationwide delivery, convenient Delivery time and cold‑chain concerns in hot weather Depends on product and PBS status
Rural Delivery Helps remote patients access medicines Longer delivery times, possible stock limits PBS concessions often applicable

How Nitrofurantoin Works — Simple And Clinical Explanations

Simplified Explanation

Nitrofurantoin is concentrated in the urine where it kills common urinary pathogens.

After bacterial enzymatic reduction it damages bacterial DNA and other macromolecules, producing bactericidal activity in the urinary tract.

Its low systemic tissue penetration makes it suitable for lower urinary tract infections but unsuitable for pyelonephritis or prostatitis.

Clinical Pharmacology Terms

ATC code: J01XE01.

Pharmacokinetics: oral absorption followed by rapid renal excretion, producing high urinary concentrations that are bactericidal.

Extended‑release 100 mg formulations such as Macrobid provide dosing convenience compared with immediate‑release multiple‑dose regimens.

  • Definitions:
  • ATC = anatomical therapeutic chemical classification.
  • Bactericidal vs Bacteriostatic = kills bacteria vs inhibits growth.
  • ER vs Immediate Release = extended dosing interval vs multiple daily doses.

Clinicians should choose nitrofurantoin for lower UTI when local susceptibility supports its use and avoid it for suspected upper tract infections.

Indications And Off‑Label Considerations

Approved Indications By TGA / Typical Use

Primary indication for nitrofurantoin is treatment and prophylaxis of uncomplicated cystitis in adults and children where product labelling supports use.

It is not suitable for pyelonephritis or prostatitis because of poor tissue penetration beyond the bladder.

Off‑Label Uses In Australian Clinical Practice

Off‑label prescribing of low‑dose suppressive nitrofurantoin for recurrent lower urinary tract infections is practiced by some clinicians under careful supervision.

Long‑term suppressive use carries risk of chronic adverse effects such as pulmonary reactions and peripheral neuropathy and must be documented with informed consent.

  • Checklist For Suppressive Therapy Documentation And Monitoring:
  • Baseline renal function and liver tests.
  • Baseline respiratory assessment and neuropathy screen.
  • Regular review intervals and stop criteria for emerging adverse effects.
  • Informed consent recorded in clinical notes.

Clinical Evidence Summary And Antimicrobial Resistance Trends

What does contemporary evidence show about nitrofurantoin?

Surveillance from 2022–2026 indicates nitrofurantoin remains effective for uncomplicated lower urinary tract infections where local E. coli susceptibility is high.

Resistance patterns vary by region, so clinicians should consult local antibiograms before routine use for complicated or recurrent infections.

Safety reports emphasise rare but serious pulmonary reactions and peripheral neuropathy, especially with prolonged therapy or in renal impairment.

Antimicrobial stewardship recommends using the shortest effective course and reserving nitrofurantoin for appropriate lower UTI indications.

  • Efficacy: Good for lower UTI when local susceptibility supports use.
  • Resistance: Regional variation—check local antibiogram.
  • Safety Signals: Rare pulmonary toxicity and neuropathy with long use.
  • Stewardship: Use shortest effective course, culture in recurrent or failed cases.

Alternatives And How They Compare (Practical Matrix)

PBS‑Listed Alternatives Comparison Table

Agent Typical Indication Advantages Disadvantages PBS Status
Fosfomycin Uncomplicated cystitis Single‑dose convenience Availability and PBS listing vary Check PBS for current subsidy
Trimethoprim Uncomplicated UTI Good oral bioavailability Resistance in some regions; avoid in pregnancy Check PBS for listing
Sulfamethoxazole‑Trimethoprim Uncomplicated and some complicated UTI Broad spectrum Allergy risk; interactions; resistance concerns Check PBS for listing
Ciprofloxacin Complicated UTI, pyelonephritis Good tissue penetration Fluoroquinolone side effects and resistance; not first‑line for simple cystitis Check PBS for criteria

Pros And Cons Checklist

  • Review allergy history and prior adverse reactions.
  • Consider pregnancy and breastfeeding status.
  • Check renal and hepatic function before choosing an alternative.
  • Consult local resistance data and severity (upper vs lower UTI).
  • Discuss side effect profiles and dosing convenience with the patient.

Pharmacy FAQ — Answers Pharmacists Give Patients

What are the questions patients ask most often at the pharmacy?

“Is it safe in pregnancy?” — Avoid nitrofurantoin after 38 weeks of pregnancy and discuss alternatives earlier in pregnancy as appropriate.

“Why is my urine brown?” — Brown urine is a harmless metabolite and not a cause for alarm, but document and reassure the patient.

“How long until symptom relief?” — Many patients feel relief within 24–48 hours, but complete the prescribed course and seek review if symptoms persist.

“Can I take it with other medicines?” — Review drugs that affect renal clearance and check oxidant drugs if G6PD status is uncertain.

Use this short counselling script at supply to ensure key points are covered.

  • Counselling Script:
  • Confirm identity, allergies and reason for antibiotic.
  • Explain dosing schedule and food advice.
  • Highlight common side effects and rare red flags.
  • Advise when to seek urgent care and arrange follow‑up if symptoms persist 48–72 hours.

Price And Access — Practical Comparison For Australian Patients

Comparison Table (Pharmacy/Source, Price Range, PBS Subsidy Status)

Pharmacy/Source Typical Price Range PBS Subsidy Status
Chemist Warehouse Varies by brand and pack size (generics cheaper) Depends on product and prescribing criteria
Priceline Varies; check online and in‑store Depends on PBS listing
TerryWhite Chemmart Varies; pharmacist can advise on generics Depends on PBS eligibility
Approved Online Pharmacies Often similar to retail; delivery fees may apply Depends on product and PBS criteria

Access Checklist — Urban Vs Rural Differences

  • Check local pharmacy stock before travel or if living in rural areas.
  • Consider online ordering with tracked delivery for remote locations.
  • Use telehealth for e‑prescriptions when GP access is limited.
  • Bring concession cards or request generic substitutions to reduce cost.

Registration, Regulation And Reporting In Australia

TGA Approval And Product Registration

Clinicians should verify specific nitrofurantoin products on the TGA ARTG for approved indications, labelling and product details.

The supplied product data confirms nitrofurantoin is prescription‑only in all jurisdictions.

PBS Subsidy Details And Prescribing Rules

PBS listings and subsidy criteria change; check the PBS schedule before prescribing to determine eligibility and repeats.

For telehealth e‑scripts, follow current Medicare and TGA guidance to ensure lawful electronic prescribing and dispensing.

Report suspected adverse events to the TGA via the Adverse Event Management system to contribute to national safety monitoring.

  • Definitions:
  • ARTG = Australian Register of Therapeutic Goods.
  • PBS = Pharmaceutical Benefits Scheme.
  • TGA Adverse Reporting = national reporting mechanism for suspected reactions.
  • Procedural Checklist For Clinicians:
  • Verify ARTG listing for the exact product before prescribing.
  • Confirm PBS subsidy criteria if cost is a concern for the patient.
  • Document counselling and any monitoring arrangements in the record.

Storage, Transport And Cold‑Chain Considerations For Australia

Household Storage (Heat/Humidity)

Store nitrofurantoin at room temperature away from moisture and heat.

In Australian homes, keep medicines in a cool, dry cabinet away from bathrooms and direct sunlight.

Oral suspensions should be shaken well and refrigerated only if the leaflet specifies refrigeration.

Always keep child‑proof caps in place and out of reach of children.

Pharmacy Cold‑Chain And Dispensing Handling

Most nitrofurantoin products do not require refrigeration but should be protected from excessive heat, especially during summer deliveries.

When dispatching to rural areas in hot weather, use insulated packaging to avoid heat exposure.

Provide clear storage instructions on the dispensing label and in the consumer medicine information.

  • Patient Counselling Checklist:
  • Store at room temperature away from heat and moisture.
  • Follow any refrigeration advice on the label for suspensions.
  • Observe expiry dates and dispose of leftover antibiotics safely.

Practical Counselling And Monitoring Guidance For Australian Pharmacists

Australian Pharmacist Counselling Style

Use a patient‑centred, plain‑language approach when counselling about nitrofurantoin or furadantin.

Confirm the indication, dosing schedule and duration before supply.

Explain that common side effects include nausea and brown urine and that rare but serious signals include breathlessness or numbness.

Advise patients to stop the medicine and seek immediate review if pulmonary or neurological symptoms appear.

Patient Monitoring And PBS/National Guidance

Recommend baseline renal checks for at‑risk patients and document counselling in dispensing records.

For prophylactic or long‑term suppressive therapy, schedule regular reviews and stop therapy if adverse effects develop.

  • Printable Patient Checklist:
  • Exact dose times and whether to take with food.
  • Red‑flag symptoms and emergency contact instructions.
  • Missed‑dose instructions and expiry/disposal guidance.

Provide a brief pill‑card template with dose times and prescriber contact details for patient convenience.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9‑14 days
Melbourne Victoria 9‑14 days
Brisbane Queensland 9‑14 days
Perth Western Australia 9‑14 days
Adelaide South Australia 9‑14 days
Canberra Australian Capital Territory 9‑14 days
Hobart Tasmania 9‑14 days
Darwin Northern Territory 9‑14 days
Gold Coast Queensland 14‑21 days
Newcastle New South Wales 14‑21 days
Wollongong New South Wales 14‑21 days
Sunshine Coast Queensland 14‑21 days
Geelong Victoria 14‑21 days

Related products